Artemis Medicare Services Q2 FY27 Results: Consolidated Net Profit ₹31.10 Crore on Total Income of ₹319 Crore
Earnings
Hospitals and healthcare services
Blacklitt Research3 min read
Artemis Medicare Services (NSE: ARTEMISMED) reported consolidated total income of ₹319.12 crore and net profit of ₹31.10 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹313.89 crore and net profit of ₹30.95 crore, it said in a filing on 30 Oct 2026.
Key highlights
Consolidated
Including its subsidiaries
Total income: ₹319.12 crore, up 13.0% YoY and 9.0% QoQ
Net profit and EPS: ₹31.10 crore, up 3.7% YoY; basic EPS ₹1.96 against ₹1.90
Depreciation: ₹14.50 crore, up 23.8% YoY
Finance costs: ₹7.42 crore, up 3.2% YoY
Standalone
The company on its own, without its subsidiaries
Total income: ₹313.89 crore, up 13.1% YoY and 9.2% QoQ
Net profit and EPS: ₹30.95 crore, up 3.3% YoY; basic EPS ₹1.96 against ₹1.90
Depreciation: ₹14.12 crore, up 25.7% YoY
Finance costs: ₹7.39 crore, up 6.5% YoY
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
319.12
282.36
+13.0%
292.70
+9.0%
Revenue from operations
311.04
274.70
+13.2%
287.32
+8.3%
Other income
8.08
7.65
+5.5%
5.37
+50.3%
31.10
30.00
+3.7%
31.44
-1.1%
Profit before tax
40.98
39.38
+4.1%
42.63
-3.9%
Finance costs
7.42
7.19
+3.2%
6.46
+14.8%
Depreciation
14.50
11.71
+23.8%
12.73
+13.9%
Tax expense
9.88
9.37
+5.4%
11.19
-11.7%
Net profit margin
9.75%
10.63%
-0.88 pp
10.74%
-1.00 pp
EPS, basic (₹)
1.96
1.90
+3.2%
1.98
-1.0%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Income grew faster than profit this quarter. Total income rose 13.0% to ₹319.12 crore, while net profit rose 3.7% to ₹31.10 crore and profit before tax rose 4.1% to ₹40.98 crore. Depreciation rose 23.8% to ₹14.50 crore, and finance costs rose 3.2% to ₹7.42 crore. Net profit attributable to shareholders of the company was ₹31.03 crore, against ₹29.97 crore a year earlier. Net profit margin was 9.75%, against 10.63% a year earlier.
Other income is a small part of the total, at ₹8.08 crore: 2.5% of total income and 19.7% of profit before tax. Tax expense of ₹9.88 crore is 24.1% of profit before tax, against ₹9.37 crore a year earlier.
Against the previous quarter, total income rose 9.0% while net profit fell 1.1%. The statements show an exceptional item of ₹3.07 crore for the Labour Code impact in the year ended 31 Mar 2026 column, and none in the quarter ended 30 Sep 2026.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
313.89
277.57
+13.1%
287.41
+9.2%
Revenue from operations
305.71
269.78
+13.3%
282.01
+8.4%
Other income
8.18
7.78
+5.1%
5.40
+51.6%
30.95
29.96
+3.3%
31.05
-0.3%
Profit before tax
40.76
39.77
+2.5%
42.11
-3.2%
Finance costs
7.39
6.93
+6.5%
6.42
+15.0%
Depreciation
14.12
11.24
+25.7%
12.35
+14.3%
Tax expense
9.81
9.80
+0.1%
11.06
-11.3%
Net profit margin
9.86%
10.80%
-0.93 pp
10.80%
-0.94 pp
EPS, basic (₹)
1.96
1.90
+3.2%
1.96
0.0%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone total income rose 13.1% to ₹313.89 crore and net profit rose 3.3% to ₹30.95 crore, while profit before tax rose 2.5% to ₹40.76 crore. Tax expense of ₹9.81 crore was almost unchanged from ₹9.80 crore a year earlier, and is 24.1% of profit before tax. Depreciation rose 25.7% to ₹14.12 crore. Net profit margin was 9.86%, against 10.80% a year earlier.
Standalone finance costs of ₹7.39 crore are 2.4% of total income, and rose 6.5% from a year earlier. Consolidated net profit of ₹31.10 crore is ₹0.15 crore higher than standalone, and consolidated net profit rose 3.7% YoY against 3.3% for standalone. The standalone cash flow statement shows deposits or advances given for new acquisitions of ₹54.00 crore in the six months ended 30 Sep 2026.
Inference
The board approved the results on 30 Oct 2026, and the statutory auditors, T R Chadha & Co LLP, issued an unmodified limited review conclusion on both standalone and consolidated results. The consolidated results include the subsidiary Artemis Cardiac Care Private Limited, whose interim results were reviewed by another auditor; its total assets were ₹22.33 crore as at 30 Sep 2026.
During the quarter the company paid a final dividend of ₹0.45 per fully paid-up equity share of ₹1 each, aggregating ₹7.12 crore, for the year ended 31 Mar 2026. Its 33,000 CCDs, aggregating ₹330.00 crore, issued to International Finance Corporation in a preferential issue, converted into 1,89,62,247 equity shares on 15 Nov 2025. Of the proceeds, ₹164.70 crore has been used for expansion, including ₹10.36 crore in the quarter, with the balance held in fixed deposits. The company commenced soft launch operations of a 300-bed multi-super speciality hospital at Raipur, Chhattisgarh, in July 2026.
Not stated: the reason for the Labour Code exceptional item, the acquisitions for which ₹54.00 crore of deposits or advances were given, and the date the Raipur hospital will reach full operation.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
ARTEMISMEDArtemis Medicare Services Ltd.
